News
Recent comments from Trump’s FDA commissioner, coupled with an anti-abortion study on mifepristone, are setting off alarm ...
U.S. District Judge Matthew Kacsmaryk granted GenBioPro “permissive intervention,” writing that the company’s filings were ...
A new study has exposed "serious adverse events" linked to mifepristone, also known as the "abortion pill." Mifepristone is a "pregnancy blocker" that is used in combination with another ...
More than one in 10 women may experience severe complications from mifepristone abortion pills, such as hemorrhaging, ...
Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, ...
This should serve as an urgent safety signal for the FDA and is more consistent with what I see in clinical practice,” said ...
Food and Drug Administration Commissioner Martin Makary said Thursday he has “no plans to take action” to restrict the ...
A first-of-its-kind study by the Ethics and Public Policy Center that delves into public-health insurance records found that ...
Two groups release studies based on same insurance claims database, finding nearly 11% rate of serious adverse reactions to ...
One in ten patients experience a “serious adverse event” after taking the abortion pill, according to a study released Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results